Delving into the Latest Updates on Bangqin Manyan Dropping Pills with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Infectious DiseasesMouth and Tooth DiseasesOtorhinolaryngologic Diseases+ [1]

Active Indication-

Inactive Indication

Chronic pharyngitis

Originator Organization

Jilin University Science and Technology Center

Active Organization-

Inactive Organization

Jilin University Science and Technology Center

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

Healthy people were selected as subjects, starting from a safe initial dose, to observe the human body's tolerance to the domestic Class VI new drug Burdock and Qinlan Manyan Dropping Pills, determine the safe and tolerable human dose, understand the adverse reactions at this dose, and provide a safe dosage range for formulating the dosing regimen for the Phase II clinical trial of this product.

Start Date14 Sep 2012

Sponsor / Collaborator

Jilin University Science and Technology Center

100 Clinical Results associated with Bangqin Manyan Dropping Pills

Login to view more data

100 Translational Medicine associated with Bangqin Manyan Dropping Pills

Login to view more data

100 Patents (Medical) associated with Bangqin Manyan Dropping Pills

Login to view more data

100 Deals associated with Bangqin Manyan Dropping Pills

Login to view more data